Research shows link between androgen deprivation therapy for prostate cancer and dementia

A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with. The study, by researchers at the Stanford University School of Medicine and the University …

Research shows link between androgen deprivation therapy for prostate cancer and dementia Read More »